183 related articles for article (PubMed ID: 15305385)
1. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.
Ninomiya I; Terada I; Yoshizumi T; Takino T; Nagai N; Morita A; Fushida S; Nishimura G; Fujimura T; Ohta T; Miwa K
Int J Cancer; 2004 Oct; 112(1):135-42. PubMed ID: 15305385
[TBL] [Abstract][Full Text] [Related]
2. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H
Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.
Zhou J; Tang ZY; Fan J; Wu ZQ; Ji Y; Xiao YS; Shi YH; Li XM; Sun QM; Liu YK; Ye SL
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6030-7. PubMed ID: 14676129
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
[TBL] [Abstract][Full Text] [Related]
5. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts.
Sawada N; Ishikawa T; Sekiguchi F; Tanaka Y; Ishitsuka H
Clin Cancer Res; 1999 Oct; 5(10):2948-53. PubMed ID: 10537364
[TBL] [Abstract][Full Text] [Related]
6. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
[TBL] [Abstract][Full Text] [Related]
7. [Discovery and development of novel anticancer drug capecitabine].
Ishitsuka H; Shimma N; Horii I
Yakugaku Zasshi; 1999 Dec; 119(12):881-97. PubMed ID: 10630095
[TBL] [Abstract][Full Text] [Related]
8. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Torigoe S; Fukumitsu T; Mizobe T; Yamashita N; Yanagawa T; Shirouzu K
J Surg Oncol; 2006 Jan; 93(1):47-55. PubMed ID: 16353181
[TBL] [Abstract][Full Text] [Related]
10. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
[TBL] [Abstract][Full Text] [Related]
11. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.
Miwa M; Ura M; Nishida M; Sawada N; Ishikawa T; Mori K; Shimma N; Umeda I; Ishitsuka H
Eur J Cancer; 1998 Jul; 34(8):1274-81. PubMed ID: 9849491
[TBL] [Abstract][Full Text] [Related]
12. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Saif MW; Black G; Johnson M; Russo S; Diasio R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
[TBL] [Abstract][Full Text] [Related]
13. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts.
Ishikawa T; Utoh M; Sawada N; Nishida M; Fukase Y; Sekiguchi F; Ishitsuka H
Biochem Pharmacol; 1998 Apr; 55(7):1091-7. PubMed ID: 9605432
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases.
Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F
Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
Morita T; Matsuzaki A; Tokue A
Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine).
Ishikawa T; Fukase Y; Yamamoto T; Sekiguchi F; Ishitsuka H
Biol Pharm Bull; 1998 Jul; 21(7):713-7. PubMed ID: 9703255
[TBL] [Abstract][Full Text] [Related]
17. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine: preclinical pharmacology studies.
Ishitsuka H
Invest New Drugs; 2000 Nov; 18(4):343-54. PubMed ID: 11081570
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.
Ouchi KF; Yanagisawa M; Sekiguchi F; Tanaka Y
Cancer Chemother Pharmacol; 2006 May; 57(5):693-702. PubMed ID: 16362295
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
